{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T04:20:03Z","timestamp":1783830003514,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish Science Board","award":["5958"],"award-info":[{"award-number":["5958"]}]},{"DOI":"10.13039\/501100003793","name":"Heart-Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vph.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T12:31:42Z","timestamp":1486729902000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries"],"prefix":"10.1016","volume":"90","author":[{"given":"Majid","family":"Sheykhzade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilofar","family":"Amandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Vidal","family":"Pla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Abdolalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Sams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Warfvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl S.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vph.2017.02.001_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1476-5381.2011.01649_1.x","article-title":"Guide to receptors and channels (GRAC), 5th edition","volume":"164","author":"Alexander","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.02.001_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"issue":"5997","key":"10.1016\/j.vph.2017.02.001_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.vph.2017.02.001_bb0020","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.110.165993","article-title":"Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries","volume":"334","author":"Chan","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2017.02.001_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple AMY receptors arise from receptor activity-modifying-proteins interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2017.02.001_bb0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist","volume":"129","author":"Doods","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.02.001_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0166-2236(85)90050-5","article-title":"Functional role of perivascular peptides in the control of cerebral circulation","volume":"8","author":"Edvinsson","year":"1985","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2017.02.001_bb0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/apha.12213","article-title":"Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries","volume":"210","author":"Edvinsson","year":"2014","journal-title":"Acta Physiol (Oxford)"},{"issue":"1\u20132","key":"10.1016\/j.vph.2017.02.001_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01532-1","article-title":"Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells","volume":"434","author":"Edvinsson","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.02.001_bb0050","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/0333102410362122","article-title":"Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries","volume":"30","author":"Edvinsson","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.vph.2017.02.001_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00934-1","article-title":"Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries","volume":"415","author":"Edvinsson","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"5789","key":"10.1016\/j.vph.2017.02.001_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vph.2017.02.001_bb0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0006-8993(87)90348-9","article-title":"Comparison of binding sites for the calcitonin gene-related peptides I and II in man","volume":"410","author":"Henke","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.vph.2017.02.001_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1748-1716.1983.tb07178.x","article-title":"Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels","volume":"117","author":"H\u00f6gest\u00e4tt","year":"1983","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.vph.2017.02.001_bb0080","series-title":"Pharmacologic Analysis of Drug-Receptor Interaction","first-page":"331","article-title":"Competitive antagonism","author":"Kenakin","year":"1997"},{"issue":"23","key":"10.1016\/j.vph.2017.02.001_bb0085","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1021\/jm3013147","volume":"55","author":"Luo","year":"2012","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.vph.2017.02.001_bb0090","doi-asserted-by":"crossref","first-page":"14294","DOI":"10.1074\/jbc.M109661200","article-title":"Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists","volume":"277","author":"Mallee","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.vph.2017.02.001_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0333102413500727","article-title":"BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial","volume":"34","author":"Marcus","year":"2014","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.vph.2017.02.001_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2009.11.076","article-title":"Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74","volume":"391","author":"Miller","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6683","key":"10.1016\/j.vph.2017.02.001_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vph.2017.02.001_bb0110","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1476-5381.2012.02129.x","article-title":"Endosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteries","volume":"167","author":"McNeish","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2017.02.001_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1476-5381.2011.01633.x","article-title":"Targeting a family B GPCR\/RAMP receptor complex: CGRP receptor antagonists and migraine","volume":"166","author":"Moore","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.02.001_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2017.02.001_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0163-7258(92)90036-Y","article-title":"Calcitonin gene-related peptide: multiple actions, multiple receptors","volume":"56","author":"Poyner","year":"1992","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vph.2017.02.001_bb0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.107.130344","volume":"324","author":"Salvatore","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.vph.2017.02.001_bb0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.109.163816","article-title":"Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist","volume":"333","author":"Salvatore","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.vph.2017.02.001_bb0140","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.bjp.0701760","article-title":"Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats","volume":"123","author":"Sheykhzade","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.vph.2017.02.001_bb0150","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjp.0705967","article-title":"Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries","volume":"143","author":"Sheykhzade","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.02.001_bb0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.str.2010.05.014","article-title":"Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism","volume":"18","author":"ter Haar","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.vph.2017.02.001_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/10799893.2013.770528","article-title":"The biological effects and mechanisms of calcitonin gene-related peptide on human endothelial cell","volume":"33","author":"Tuo","year":"2013","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"1","key":"10.1016\/j.vph.2017.02.001_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjp.0704682","article-title":"BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37)","volume":"136","author":"Verheggen","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.vph.2017.02.001_bb0170","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/bph.12129","article-title":"CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?","volume":"170","author":"Walker","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.02.001_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/bj0900293","article-title":"The separation of synaptic vesicles from nerve-ending particles (\u201csynaptosomes\u201d)","volume":"90","author":"Whittaker","year":"1964","journal-title":"Biochem. J."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116303330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116303330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:05:41Z","timestamp":1568804741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189116303330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"alternative-id":["S1537189116303330"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2017.02.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}